Dr. Florian Rieder is Vice Department Chair, Co-Section Head for IBD, and Director of the Global IBD program at the Digestive Disease Institute at the Cleveland Clinic Foundation. He received his medical degree from Ludwig-Maximilians-University Medical School in Munich, Germany, followed by advanced training in both Germany and the United States, including research fellowships at Harvard Medical School and Cleveland Clinic.

A leading international expert on IBD, Dr. Rieder’s clinical and scientific focus centers on the pathogenesis, prediction, and therapy of intestinal strictures—particularly fibrostenosis—in Crohn’s disease and ulcerative colitis. He has published more than 250 articles and book chapters, and has held influential roles as lead author of European Crohn’s and Colitis Organisation (ECCO) clinical guidelines and consensus statements. Currently, Dr. Rieder directs an NIH-funded research program and is lead Principal Investigator for the international Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium, which aims to pave the way for anti-fibrotic therapies in stricturing Crohn’s disease. He is widely recognized for his leadership in collaborative research and education, advancing hope for patients worldwide. Dr. Rieder is a member of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).